OPEN Health at the ISPOR19th Annual European Congress

Written on Thursday 20th October 2016

29th October - 2nd November marks ISPOR's 19th Annual European Congress, this year held in the Austrian Center in Vienna. The event is a great opportunity not only to attend thought-provoking plenary sessions and workshops, or view interesting podium presentations and symposia, but also to network with fellow HEOR specialists. OPEN Health will be represented at the event by our Market Access and Real World Evidence companies within the group – OPEN Access Consulting and pH Associates.

From Saturday 29th October – Wednesday 2nd November, the International Society for Pharmacoeconimcs and Outcomes Research will take over the Austrian Center Vienna to host their 19th Annual European Congress. Last year’s ISPOR 18th Annual Congress attracted over 5,000 attendees from all over the world, from global leaders, regulators, researchers, payers, patients and policy makers. This year’s congress - located just 7 minutes from downtown Vienna, next door to one of the global UN headquarters and a short walk from the Danube and Donaupark - is set to be just as successful with the opportunity to hear from renowned experts in the Health Economics and Outcomes Research (HEOR) field.

The event is a great opportunity not only to attend thought-provoking plenary sessions and workshops, or view interesting podium presentations and symposia, but also to network with fellow HEOR specialists.

OPEN Health will be represented at the event by our Market Access and Real World Evidence companies within the group – OPEN Access Consulting and pH Associates. OPEN Access Consulting and pH Associates collaborate to offer strategic market access and RWE consultancy. The highly qualified 50 strong team provide integrated market access support through expert strategic consultancy and the design and implementation of robust real world evidence programmes.

OPEN Access Consulting is a specialist Market Access agency with unrivalled experience in the delivery of market access programmes from early phase insights to generic/biosimilar strategies. Our services include reimbursement and HTA landscape assessment, evidence evaluation, data gap analysis and the development of product value strategies. Payer engagement is central to our service offerings to ensure optimal reimbursement and patient access to innovative technologies.  

pH Associates is a specialist Real World Evidence consultancy demonstrating value and outcomes to drive access through RWE.  pH specialise in identifying RWE needs and developing robust RWE plans to support  strategies across the product lifecycle.  The core services expertly conducted include the analysis of existing data sets and the generation of RWE via a range of observational study designs to create bespoke data to address the client’s needs.  The expanding expert Patient Centred Outcomes Team focusses on delivering the outcomes that really matter to patients.  

To keep up with the latest news from ISPOR 2016 search the hashtag #ISPORViennaon social media.

For more information on what OPEN Health, and specifically OPEN Access Consulting and pH Associates can offer within the HEOR field, please visit stand 208 at ISPOR 2016.

Alternatively, you can get in touch with: Sam Oliver, Joint Managing Director at pH Associates on SamOliver@phassociates.com or Dorinda Hickey, CEO of OPEN Access Consulting on DorindaHickey@openaccessconsulting.com.